Lack of Medication-Assisted Treatment Impeding Opioid Response in West Virginia, Nurse Tells Congress

This July 23, 2018 file photo shows packets of buprenorphine, a drug which controls heroin and opioid cravings, in Greenfield, Mass.

This July 23, 2018 file photo shows packets of buprenorphine, a drug which controls heroin and opioid cravings, in Greenfield, Mass. Elise Amendola/AP Photo

 

Connecting state and local government leaders

Medical experts offered their assessment of the federal government’s approach to combating the opioid crisis before the House Oversight and Reform Committee.

Huge gaps in access to medication-assisted treatment and the failure of federal funding to materialize in communities overrun by opioids are hampering efforts to stem the crisis in West Virginia, a nursing director told a congressional committee on Wednesday.

Testifying before the House Oversight and Reform Committee, Angela Gray described the obstacles that continue to prevent West Virginians from receiving opioid addiction and recovery care. The nursing director for the Berkeley-Morgan County Board of Health told lawmakers that despite federal efforts to appropriate funding for state and local opioid treatment, there are still significant barriers preventing people in the state from receiving care.

“My state is hemorrhaging and without long-term funding and commitment and planning, we will continue to bleed,” Gray said. “We need infrastructure support.”

An estimated 130 Americans die every day from opioid-involved overdoses, according to the Centers for Disease Control and Prevention, and West Virginia ranks highest for overdose death rates in the country.

The federal government has appropriated billions of dollars for opioid-related matters in recent years, funding law enforcement efforts meant to crack down on the trafficking of fentanyl, heroin and carfentanil, a synthetic opioid; distribution of the opioid-overdose reversal drug naloxone; and state and local grants to expand access to medication assisted treatment (MAT) drugs.  

But Gray told lawmakers that recent appropriations, specifically the U.S. Department of Health and Human Services administered State Opioid Response grants, have not yet trickled down to the county-level clinics where she works.

“To this date, none of the SOR money has hit the community level. I have not seen one penny,” Gray said.

HHS awarded West Virginia $14.6 million in SOR funding this year.

While the SUPPORT for Patients and Communities Act, signed into law by President Trump in 2018, requires Medicaid to cover medication-assisted treatment, Gray said there are still large gaps in MAT treatment available in rural parts of West Virginia. That kind of treatment combines behavioral therapy with prescription of a medication that lessens or blocks the high a patient gets from opioids, while also relieving their cravings.  

“We have very few MAT providers in either of the counties I work in,” she said. “In Morgan County, I only have one and they only see people one day a month.”

Doctors must obtain waivers before they are able to prescribe the three Food and Drug Administration-approved MAT drugs: methadone, buprenorphine, and naltrexone.

While more prescribers are obtaining waivers, there is still a hesitancy to do so, Gray said.

At Wednesday’s hearing, Oversight Committee Chairman Rep. Elijah Cummings advocated for passage of the Comprehensive Addiction Resources Emergency (CARE) Act, which he introduced with Sen. Elizabeth Warren. The bill, which is modeled after the Ryan White Comprehensive AIDS Resources Emergency Act of 1990, would allot $100 billion in federal funding over ten years to address the opioid crisis.

Cummings, a Maryland Democrat, said the legislation would go further than the SUPPORT Act, passed by Congress last year, in funding state and local drug treatment efforts and wrap-around services needed to help individuals overcome drug addiction.

Addiction treatment experts who testified at Wednesday’s hearing echoed concern that although MAT is proven to work, administrative barriers are preventing people from getting access to the treatment.  

“Only a small portion, maybe one-third of people with opioid use disorder receive any type of treatment and only a small set of those receive MAT,” said Susan Bailey, president-elect of the American Medical Association.

Obstacles reducing access include requirements by commercial insurers, Medicare, and Medicaid for individuals to have prior authorization for the treatment, Bailey told lawmakers. Maryland was the first state to do away with prior authorization requirements for MAT in 2017, but at least 15 states have pursued similar initiatives since then, Bailey said.

At Wednesday’s hearing, Oversight Committee Ranking member Jim Jordan, an Ohio Republican, stressed the importance of providing access to treatment but also cracking down on the supply chain of narcotics smuggled across the southern border into the United States.

Gray responded urging lawmakers to provide similar levels of funding for treatment as they do for law enforcement prevention efforts. If the underlying addiction isn’t treated, people will just bounce from one drug to the next, Gray said—something she’s already seen play out with methamphetamines in West Virginia.

“I can trace it in my clinic. Whenever there has been a hit on the opioid or heroin supply it’s going to be a heavily meth clinic,” Gray said. “They haven’t addressed the addiction so they move to the next drug that keeps them going. And you can make meth in your home. You can make it in a backpack. So, unless we really put some serious effort in to treating addiction, you can hit that supply all you want.”

Andrea Noble is a staff correspondent for Route Fifty.

FEATURED CASE STUDIES
Powered By The Atlas
City of Coral Gables Leverages the Internet of Things to Improve Quality of Life
Coral Gables, FL, USA
Corpus Christi Deploys COVID Management System to Improve Data & Eliminate Time-Consuming Tasks
Corpus Christi, TX, USA
Nightlife economy conflicts reduced in the City of Longmont with sound monitors.
Longmont, CO, USA

NEXT STORY: Texas Is Latest State To Attack Surprise Medical Bills

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.